These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18716801)

  • 1. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.
    Lu CS; Wu-Chou YH; van Doeselaar M; Simons EJ; Chang HC; Breedveld GJ; Di Fonzo A; Chen RS; Weng YH; Lai SC; Oostra BA; Bonifati V
    Neurogenetics; 2008 Oct; 9(4):271-6. PubMed ID: 18716801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
    Tan EK; Zhao Y; Skipper L; Tan MG; Di Fonzo A; Sun L; Fook-Chong S; Tang S; Chua E; Yuen Y; Tan L; Pavanni R; Wong MC; Kolatkar P; Lu CS; Bonifati V; Liu JJ
    Hum Genet; 2007 Feb; 120(6):857-63. PubMed ID: 17019612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
    Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
    Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
    Di Fonzo A; Wu-Chou YH; Lu CS; van Doeselaar M; Simons EJ; Rohé CF; Chang HC; Chen RS; Weng YH; Vanacore N; Breedveld GJ; Oostra BA; Bonifati V
    Neurogenetics; 2006 Jul; 7(3):133-8. PubMed ID: 16633828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the LRRK2 Gly2385Arg variant in Alzheimer's disease in Taiwan.
    Chang TY; Kuo HC; Lu CS; Wu-Chou YH; Huang CC
    Parkinsonism Relat Disord; 2010 Jan; 16(1):28-30. PubMed ID: 19640773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    An XK; Peng R; Li T; Burgunder JM; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Zhang ZJ
    Eur J Neurol; 2008 Mar; 15(3):301-5. PubMed ID: 18201193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.
    Fung HC; Chen CM; Hardy J; Singleton AB; Wu YR
    BMC Neurol; 2006 Dec; 6():47. PubMed ID: 17187665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
    Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
    Chan DK; Ng PW; Mok V; Yeung J; Fang ZM; Clarke R; Leung E; Wong L
    J Neural Transm (Vienna); 2008 Sep; 115(9):1275-7. PubMed ID: 18523722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan.
    Miyake Y; Tsuboi Y; Koyanagi M; Fujimoto T; Shirasawa S; Kiyohara C; Tanaka K; Fukushima W; Sasaki S; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    J Neurol Sci; 2010 Oct; 297(1-2):15-8. PubMed ID: 20673920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians.
    Tan EK; Zhao Y; Tan L; Lim HQ; Lee J; Yuen Y; Pavanni R; Wong MC; Fook-Chong S; Liu JJ
    Mov Disord; 2007 Sep; 22(12):1816-8. PubMed ID: 17659642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of LRRK2 P755L variant in Parkinson's disease.
    Tan EK; Lim HQ; Yuen Y; Zhao Y
    Mov Disord; 2008 Apr; 23(5):734-6. PubMed ID: 18265005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 A419V is not associated with Parkinson's disease in different Chinese populations.
    Wu YR; Tan LC; Fu X; Chen CM; Au WL; Chen L; Chen YC; Prakash KM; Zheng Y; Lee-Chen GJ; Zhao Y; Zeng JS; Tan EK; Pei Z
    PLoS One; 2012; 7(7):e36123. PubMed ID: 22807999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease.
    Tan EK
    Ann Acad Med Singap; 2006 Nov; 35(11):840-2. PubMed ID: 17160203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease.
    Tan EK; Lee J; Chen CP; Wong MC; Zhao Y
    Neurobiol Aging; 2009 Mar; 30(3):501-2. PubMed ID: 17720280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
    Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
    Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.
    Zhang P; Wang Q; Jiao F; Yan J; Chen L; He F; Zhang Q; Tian B
    Sci Rep; 2016 Nov; 6():35171. PubMed ID: 27812003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson's disease in southern China.
    Zheng Y; Liu Y; Wu Q; Hong H; Zhou H; Chen J; Wang H; Xian W; Li J; Liu Z; Pei Z; Chen L
    Eur J Neurol; 2011 Mar; 18(3):538-40. PubMed ID: 20629711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 G2019S founder haplotype in the Chinese population.
    Tan EK; Skipper L; Tan L; Liu JJ
    Mov Disord; 2007 Jan; 22(1):105-7. PubMed ID: 17083102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.